High-dose cytosine arabinoside-induced cutaneous reactions

Journal of the European Academy of Dermatology and Venereology

Volumn 16, Issue 5, 2002, Pages 481-485

  Cetkovska P ^a   Pizinger, K ^a   Cetkovsky P ^a,b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

Adverse effects; Cutaneous toxicity; High dose cytosine arabinoside

Indexed keywords

CORTICOSTEROID; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; PYRIDOXINE; STEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; ERYTHEMA; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SIDE EFFECT; SKIN EDEMA; SKIN MANIFESTATION; SKIN TOXICITY; URTICARIA;

ADOLESCENT; ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CYTARABINE; DRUG ERUPTIONS; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0036750512     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2002.00395.x     Document Type: Article

References (18)

1. Bolwell BJ, Cassileth PA, Gale RP. High dose cytarabine: a review. Leukemia 1988; 2: 253-260.
2. Whitlock JA, Wells RJ, Hord JD et al. High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia 1997; 11: 185-189.
3. Richards Ch, Wujcik D. Cutaneous toxicity associated with high-dose cytosine arabinoside. Oncol Nurs Forum 1992; 19: 1191-1195.
4. Litt J. Drug Eruption Reference Manual. Parthenon Publishing, New York, 1997: 129-130.
5. Cetkovská P, Pizinger K, Şkopek P. Cutaneous toxicity associated with high-dose cytosine arabinoside. J Eur Acad Dermatol Venereol 1997; 9 (Suppl. 1): S151 (Abstr.).
6. Baack BR, Burgdorf WHC. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991; 24: 457-461.
7. Blanca M, Torres MJ, Giron M et al. Successful administration of cytarabine after a previous anaphylactic reaction. Allergy 1997; 52: 1009-1011.
8. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367-398.
9. Walker IR, Wilson WEC, Sauder DN et al. Cytarabine-induced palmar-plantar erythema. Arch Dermatol 1985; 121: 1240-1241.
10. Waltzer JF, Flowers FP. Bullous variant of chemotherapy-induced acral erythema. Arch Dermatol 1993; 129: 43-45.
11. Allegue F, Soria C, Rocamora A et al. Neutrophilic: eccrine hidradenitis in two nentropenic patients. J Am Acad Dermatol 1990; 23: 1110-1113.
12. Thorisdottir K, Tomecki KJ, Bergfeld WF, Andersen SW. Neutrophilic eccrine hidradenitis. J Am Acad Dermatol 1993; 28: 775-777.
13. Hurt MA, Halvorson RD, Charles Petr F et al. Eccrine squamous syringometaplasia. Arch Dermatol 1990; 126: 73-7.
14. Ahmed I, Chen KR, Nakayama H, Gibson LE. Cytosine arabinoside-induced vasculitis. Mayo Clin Proc 1998; 73: 239-242.
15. Yokel BK, Hood AF. Mucocutaneous complications of antineoplastic therapy. In: Fitzpatrick, TB, Eisen, AZ, Wolff, K et al., editors. Dermatology in General Medicine. McGraw-Hill, New York, 1993: 1800.
16. Williams JV, Helm KF, Long D. Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster. J Am Acad Dermatol 1999; 40: 643-644.
17. Brown J, Burck K, Black D, Collins C. Treatment of cytarabine acral erythema with corticosteroids. J Am Acad Dermatol 1991; 24: 1023-1024.
18. DeSpain JD. Dermatologic toxicity of chemotherapy. Semin Oncol 1992; 19: 501-507.